Cancer Research · 2014 · 70 citations · 40 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyNeoplasiaAngiogenesis In CancerCancer MetabolismKidney CancerRenal Cell CarcinomaRenal NeoplasmsTumor Suppressor GenesHypoxia-inducible Factor ActivationHypoxia-inducible Factor SignalingManganese Superoxide DismutaseMurine ModelsNadph Oxidase ActivityNadph Oxidase BiologyPathogenic EffectsVon Hippel-lindau Disease
Most sporadically occurring renal tumors include a functional loss of the tumor suppressor von Hippel Lindau (VHL). Development of VHL-deficient renal cell carcinoma (RCC) relies upon activation of the hypoxia-inducible factor-2α (HIF2α), a master transcriptional regulator of genes that drive diverse processes, including angiogenesis, proliferation, and anaerobic metabolism. In determining the critical functions for HIF2α expression in RCC cells, the NADPH oxidase NOX4 has been identified, but the pathogenic contributions of NOX4 to RCC have not been evaluated directly. Here, we report that NOX4 silencing in VHL-deficient RCC cells abrogates cell branching, invasion, colony formation, and growth in a murine xenograft model RCC. These alterations were phenocopied by treatment of the superoxide scavenger, TEMPOL, or by overexpression of manganese superoxide dismutase or catalase. Notably, NOX4 silencing or superoxide scavenging was sufficient to block nuclear accumulation of HIF2α in RCC cells. Our results offer direct evidence that NOX4 is critical for renal tumorigenesis and they show how NOX4 suppression and VHL re-expression in VHL-deficient RCC cells are genetically synonymous, supporting development of therapeutic regimens aimed at NOX4 blockade.
40
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Identification of Renox, an NAD(P)H oxidase in kidney
Miklós Geiszt, Jeffrey B. Kopp, Péter Várnai et al. · Proceedings of the National Academy of Sciences · 2000 · 829 citations